The basic profile of the BKG Vet Pharma compound:

• New Classes of antimicrobials
• Potent against multi-resistant bacteria such as MRSA despite their resistance mechanisms
• Synergistic effect in combination with common classic antibiotics
• Reversal of resistance to common antibiotics
• Difficult to induce resistance in bacteria against the New Classes of Compounds
• Oral, i.v, i.m, topical administration
• Extensive veterinary market potential
• Broad target profile
• Easy and inexpensive to synthesize
• Efficacious in key animal models at doses < NOAEL